Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Epilepsy
Trial · NCT00957372
Adverse events64
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 64
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Dizziness | Nervous system disorders | Placebo | 9 | 87 | 9 |
| other | Dizziness | Nervous system disorders | ESL 800 mg | 16 | 85 | 16 |
| other | Dizziness | Nervous system disorders | ESL 1200 mg | 24 | 80 | 24 |
| other | Dizziness | Nervous system disorders | Open-label Extension (Part II) | 33 | 194 | 33 |
| other | Somnolence | Nervous system disorders | Placebo | 8 | 87 | 8 |
| other | Somnolence | Nervous system disorders | ESL 800 mg | 11 | 85 | 11 |
| other | Somnolence | Nervous system disorders | ESL 1200 mg | 11 | 80 | 11 |
| other | Somnolence | Nervous system disorders | Open-label Extension (Part II) | 19 | 194 | 19 |
| other | Headache | Nervous system disorders | Placebo | 10 | 87 | 10 |
| other | Headache | Nervous system disorders | ESL 800 mg | 5 | 85 | 5 |
| other | Headache | Nervous system disorders | ESL 1200 mg | 8 | 80 | 8 |
| other | Headache | Nervous system disorders | Open-label Extension (Part II) | 17 | 194 | 17 |
| other | Nausea | Gastrointestinal disorders | Placebo | 1 | 87 | 1 |
| other | Nausea | Gastrointestinal disorders | ESL 800 mg | 5 | 85 | 5 |
| other | Nausea | Gastrointestinal disorders | ESL 1200 mg | 8 | 80 | 8 |
| other | Nausea | Gastrointestinal disorders | Open-label Extension (Part II) | 0 | 194 | 0 |
| other | Vomiting | Gastrointestinal disorders | Placebo | 3 | 87 | 3 |
| other | Vomiting | Gastrointestinal disorders | ESL 800 mg | 4 | 85 | 4 |
| other | Vomiting | Gastrointestinal disorders | ESL 1200 mg | 6 | 80 | 6 |
| other | Vomiting | Gastrointestinal disorders | Open-label Extension (Part II) | 11 | 194 | 11 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00957372/events